Intellia Therapeutics, Inc (NTLA)

FDA lifts clinical hold on MAGNITUDE-2 trial, boosting NTLA's prospects. Social sentiment surges on positive trial news and insider buying.

About Intellia Therapeutics, Inc

Intellia Therapeutics, Inc. is a biotechnology company focused on developing curative therapeutics using CRISPR gene editing technology.
Intellia Therapeutics, Inc uses the ticker $NTLA for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Intellia Therapeutics, Inc (NTLA) social dominance is up 696.24% from the previous week.

Price: $11.90

Price 24-Hour Time-Series Raw Data
The stock price has seen a notable increase, potentially breaking its trendline, attributed to the FDA lifting the clinical hold on the MAGNITUDE-2 trial, strong recent social sentiment, and insider buying, supported by recent posts indicating significant institutional buying.

24-Hour: 2.86% 7-Day: -3.96% 30-Day: -5.04%

1-Year High: $28 on 2025-10-20
1-Year Low: $6.30 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Intellia Therapeutics, Inc (NTLA) is currently AltRank #318 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [---]
[--] Month: [---] +563
[--] Months: [---] +336
[--] Year: [---] +356
1-Year High: [-----] on 2025-02-28
1-Year Low: [--] on 2025-11-01

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-05-02
1-Year Low: [--] on 2025-12-30

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] -60%
[--] Month: [---------] +78%
[--] Months: [----------] +36%
[--] Year: [----------] +39%
1-Year High: [-------] on 2025-10-27
1-Year Low: [-----] on 2026-02-17

Engagements by network (24h): Reddit: [--] News: [--] X: [-----] YouTube: [---] TikTok: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -1.70%
[--] Month: [-----] +82%
[--] Months: [-----] +43%
[--] Year: [------] +56%
1-Year High: [---] on 2025-10-30
1-Year Low: [--] on 2025-12-21

Mentions by network (24h): Reddit: [--] News: [--] X: [---] YouTube: [--] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Intellia Therapeutics, Inc (NTLA) in the last [--] hours which is up 2.30% from [--] in the previous [--] hours Daily Average: [---]
[--] Week: [---] -3.60%
[--] Month: [---] +57%
[--] Months: [-----] +2.70%
[--] Year: [-----] +155%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-17

The most influential creators that mention Intellia Therapeutics, Inc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@GeneInvesting	[--]	[------]	[--]	[-----]
@ayesha35421	[--]	[--]	[--]	[---]
@BRSreality	[--]	[---]	[--]	[---]
@StockSavvyShay	[--]	[-------]	[--]	[---]
@KlausMolle	[--]	[--]	[--]	[--]
@mmr9218222szmh	[--]	[---]	[--]	[--]
@Stock_Analysis9	[--]	[--]	[--]	[--]
@StockConsultant	[--]	[-----]	[--]	[--]
@shabeezy84	[--]	[--]	[--]	[--]
@mariostario2019	[--]	[--]	[--]	[--]

Sentiment: 85%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 85%
Daily Average: 76%
[--] Week: 20% -69%
[--] Month: 68% +13%
[--] Months: 68% -19%
[--] Year: 68% -20%
1-Year High: 97% on 2025-06-27
1-Year Low: 30% on 2025-05-29

Most Supportive Themes:

Gene Therapy Potential: (45%) The long-term potential of gene editing technology, particularly in treating genetic diseases, remains a key supportive theme.
Company Resilience: (30%) Despite setbacks, some believe in Intellia's ability to overcome challenges and continue developing life-saving treatments.
Acquisition Opportunities: (15%) The current stock price dip is seen by some as a potential buying opportunity for future growth.

Most Critical Themes:

FDA Clinical Hold: (10%) The FDA's clinical hold on trials due to safety concerns, specifically liver toxicity (Hy's Law), is the primary critical theme.

Social Dominance: 0.011%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.011%
Daily Average: 0.029%
[--] Week: 0.106% +0.093%
[--] Month: 0.03% +0.0095%
[--] Months: 0.03% +0.0045%
[--] Year: 0.03% -0.0088%
1-Year High: 0.083% on 2025-11-15
1-Year Low: 0.0088% on 2025-12-21

Market Dominance: 0.00156%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00156%
Daily Average: 0%
1-Year High: 0.00364% on 2025-10-20
1-Year Low: 0.00098% on 2025-05-30

Market Cap: $1,377,217,820

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,377,217,820
Daily Average: $1,229,906,355
[--] Week: $1,377,217,820 -3.80%
[--] Month: $1,374,901,222 -5%
[--] Months: $1,374,901,222 +25%
[--] Year: $1,374,901,222 +26%
1-Year High: $3,003,565,870 on 2025-10-20
1-Year Low: $650,089,649 on 2025-04-08

Top Intellia Therapeutics, Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"As of Feb [--] [----] no confirmed news or announcements indicate a $NTLA buyout. Recent developments focus on clinical progress and insider buying suggesting independent growth. Probability is low (around 10-15%) but speculative. Potential buyers might include Regeneron (existing partner) Novartis or Vertex. https://twitter.com/i/web/status/2023495969560494350 https://twitter.com/i/web/status/2023495969560494350"
X Link @grok 2026-02-16T20:33Z 8M followers, [---] engagements

"@GeneInvesting @grok and @GeneInvesting Will $NTLA be bought out Percentage of probability according to your knowledge and main potential buyers"
X Link @SignoGnazio 2026-02-16T20:32Z [---] followers, [---] engagements

"Anyone trying to talk about gene editing this holiday Pretty dead on here when market is closed. Questions Comments Thoughts 💭 $NTLA $PRME $BEAM $CRSP"
X Link @GeneInvesting 2026-02-16T18:40Z 15.3K followers, [----] engagements

"$VRTX vs $REGN vs $ALNY Stock Comparison: Earnings Recap as Vertexs Steady CF Engine Meets Regenerons EYLEA Test and Alnylams Profit Breakthrough $CRSP $NTLA $VKTX $BEAM $INCY $BMRN https://tickeron.com/pick-the-best/ALNY-or-REGN-or-VRTX/ https://tickeron.com/pick-the-best/ALNY-or-REGN-or-VRTX/"
X Link @Tickeron 2026-02-16T11:40Z 19.3K followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing